The FAMHP publishes its annual report for 2019
As is customary and with full transparency, the FAMHP publishes the figures and results for 2019 for all its services and activities.
You are receiving this annual report later than you would normally expect from us, as the COVID-19 health crisis has been given priority over the past year. The annual report contains many novelties, rising and falling trends and interesting figures. 2019 was a year of progress, you can read all about it in the FAMHP digital annual report, which is available again in four languages.
In 2019, the FAMHP services closed more than 8,097 authorization files for medicines, conducted 2,281 inspections and investigations and analyzed 10,364 reports of side effects, incidents and adverse reactions. In 2019, the FAMHP registered an increase in the number of reports of side effects of medicines for human and veterinary use, and in the number of reports of incidents involving medical devices.
2019 was also the year in which we wanted to serve patients as much as possible with new, user-friendly online applications. The FAMHP launched the online application PharmaStatus, providing information on the availability of medicines, and the online form for patients to report adverse reactions to medicines was thoroughly revised.
A lot of preparatory work was done in 2019. Dossiers such as the Brexit, the joint move to the Galilee building with our colleagues of the FPS Health and the NIHDI, the Redesign project in which we are working together with the same colleagues on synergies and a common service ... It was indispensable work behind the scenes of which we are now seeing the results.
My sincere thanks to all FAMHP staff members and external partners for their investment in the agency’s activities to serve our fellow citizens. Only by working together we have been able to achieve these results, and only together we will be ready for new challenges.